Draghia-Akli Ruxandra bought NVAX
March 2, 2026 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 139,500 shares of Novavax, Inc. at $9.09 per share, a transaction worth $1.27M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
139,500
Price
$9.09
Total value
$1.27M
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityNon-Statutory Stock Opotion NQ
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 5, 2026
Shares owned after139,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One quarter of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.